nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloropyramine—PTK2—Syndecan-4-mediated signaling events—TNC—bile duct cancer	0.0512	0.0512	CbGpPWpGaD
Chloropyramine—PTK2—Signaling of Hepatocyte Growth Factor Receptor—HGF—bile duct cancer	0.0307	0.0307	CbGpPWpGaD
Chloropyramine—PTK2—Overview of nanoparticle effects—PTGS2—bile duct cancer	0.0276	0.0276	CbGpPWpGaD
Chloropyramine—PTK2—Signaling of Hepatocyte Growth Factor Receptor—MET—bile duct cancer	0.0242	0.0242	CbGpPWpGaD
Chloropyramine—PTK2—Integrins in angiogenesis—TGFBR2—bile duct cancer	0.0204	0.0204	CbGpPWpGaD
Chloropyramine—PTK2—Angiogenesis—MMP9—bile duct cancer	0.0201	0.0201	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—ROBO2—bile duct cancer	0.0187	0.0187	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—TNC—bile duct cancer	0.0165	0.0165	CbGpPWpGaD
Chloropyramine—PTK2—Syndecan-4-mediated signaling events—MMP9—bile duct cancer	0.0159	0.0159	CbGpPWpGaD
Chloropyramine—PTK2—Nanoparticle-mediated activation of receptor signaling—NRAS—bile duct cancer	0.0157	0.0157	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HGF—bile duct cancer	0.0155	0.0155	CbGpPWpGaD
Chloropyramine—PTK2—Overview of nanoparticle effects—IL6—bile duct cancer	0.015	0.015	CbGpPWpGaD
Chloropyramine—PTK2—Angiopoietin receptor Tie2-mediated signaling—MMP2—bile duct cancer	0.0148	0.0148	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—SMAD4—bile duct cancer	0.0147	0.0147	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—GNAS—bile duct cancer	0.0145	0.0145	CbGpPWpGaD
Chloropyramine—PTK2—Nanoparticle-mediated activation of receptor signaling—EGFR—bile duct cancer	0.0143	0.0143	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—NOS2—bile duct cancer	0.0137	0.0137	CbGpPWpGaD
Chloropyramine—PTK2—Nanoparticle-mediated activation of receptor signaling—KRAS—bile duct cancer	0.0135	0.0135	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—ROBO2—bile duct cancer	0.0133	0.0133	CbGpPWpGaD
Chloropyramine—PTK2—Internalization of ErbB1—NRAS—bile duct cancer	0.0123	0.0123	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—TNC—bile duct cancer	0.0123	0.0123	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—ERBB2—bile duct cancer	0.0122	0.0122	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—MET—bile duct cancer	0.0122	0.0122	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—MMP2—bile duct cancer	0.0122	0.0122	CbGpPWpGaD
Chloropyramine—PTK2—EPHB forward signaling—NRAS—bile duct cancer	0.0121	0.0121	CbGpPWpGaD
Chloropyramine—PTK2—Nanoparticle-mediated activation of receptor signaling—HRAS—bile duct cancer	0.0115	0.0115	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—TGFBR2—bile duct cancer	0.0113	0.0113	CbGpPWpGaD
Chloropyramine—PTK2—Internalization of ErbB1—EGFR—bile duct cancer	0.0112	0.0112	CbGpPWpGaD
Chloropyramine—PTK2—IGF1 pathway—HRAS—bile duct cancer	0.0109	0.0109	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—SMAD4—bile duct cancer	0.0107	0.0107	CbGpPWpGaD
Chloropyramine—PTK2—Nongenotropic Androgen signaling—HRAS—bile duct cancer	0.0106	0.0106	CbGpPWpGaD
Chloropyramine—PTK2—Internalization of ErbB1—KRAS—bile duct cancer	0.0106	0.0106	CbGpPWpGaD
Chloropyramine—PTK2—EPHB forward signaling—KRAS—bile duct cancer	0.0104	0.0104	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—ERBB2—bile duct cancer	0.0103	0.0103	CbGpPWpGaD
Chloropyramine—PTK2—Alpha 6 Beta 4 signaling pathway—HRAS—bile duct cancer	0.0101	0.0101	CbGpPWpGaD
Chloropyramine—PTK2—Signaling of Hepatocyte Growth Factor Receptor—HRAS—bile duct cancer	0.00986	0.00986	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—ERBB2—bile duct cancer	0.0094	0.0094	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—MMP9—bile duct cancer	0.00916	0.00916	CbGpPWpGaD
Chloropyramine—PTK2—Internalization of ErbB1—HRAS—bile duct cancer	0.00902	0.00902	CbGpPWpGaD
Chloropyramine—PTK2—EPH-Ephrin signaling—MMP2—bile duct cancer	0.00896	0.00896	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events regulated by Ret tyrosine kinase—HRAS—bile duct cancer	0.00883	0.00883	CbGpPWpGaD
Chloropyramine—PTK2—EPHB forward signaling—HRAS—bile duct cancer	0.00883	0.00883	CbGpPWpGaD
Chloropyramine—PTK2—EPHB-mediated forward signaling—HRAS—bile duct cancer	0.00848	0.00848	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—EGFR—bile duct cancer	0.00848	0.00848	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—MET—bile duct cancer	0.00818	0.00818	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—KRAS—bile duct cancer	0.00801	0.00801	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—NRAS—bile duct cancer	0.00783	0.00783	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—HGF—bile duct cancer	0.00775	0.00775	CbGpPWpGaD
Chloropyramine—PTK2—NCAM signaling for neurite out-growth—NRAS—bile duct cancer	0.00774	0.00774	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—EGFR—bile duct cancer	0.0074	0.0074	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—MMP9—bile duct cancer	0.00737	0.00737	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—bile duct cancer	0.00713	0.00713	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—TP53—bile duct cancer	0.00712	0.00712	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.00687	0.00687	CbGpPWpGaD
Chloropyramine—PTK2—Primary Focal Segmental Glomerulosclerosis FSGS—TGFB1—bile duct cancer	0.00687	0.00687	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—HRAS—bile duct cancer	0.00681	0.00681	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—KRAS—bile duct cancer	0.00674	0.00674	CbGpPWpGaD
Chloropyramine—PTK2—EPH-Ephrin signaling—MMP9—bile duct cancer	0.00673	0.00673	CbGpPWpGaD
Chloropyramine—PTK2—NCAM signaling for neurite out-growth—KRAS—bile duct cancer	0.00666	0.00666	CbGpPWpGaD
Chloropyramine—PTK2—Fc-epsilon receptor I signaling in mast cells—HRAS—bile duct cancer	0.00617	0.00617	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—MET—bile duct cancer	0.00612	0.00612	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—TP53—bile duct cancer	0.00599	0.00599	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—HRAS—bile duct cancer	0.00594	0.00594	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—bile duct cancer	0.00573	0.00573	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—EGFR—bile duct cancer	0.00568	0.00568	CbGpPWpGaD
Chloropyramine—PTK2—NCAM signaling for neurite out-growth—HRAS—bile duct cancer	0.00566	0.00566	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—TGFB1—bile duct cancer	0.00565	0.00565	CbGpPWpGaD
Chloropyramine—PTK2—NCAM signaling for neurite out-growth—IL6—bile duct cancer	0.00542	0.00542	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—NRAS—bile duct cancer	0.00538	0.00538	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—HRAS—bile duct cancer	0.00523	0.00523	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—NRAS—bile duct cancer	0.00508	0.00508	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—ERBB2—bile duct cancer	0.00508	0.00508	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—bile duct cancer	0.00497	0.00497	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—KRAS—bile duct cancer	0.00463	0.00463	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—ERBB2—bile duct cancer	0.00447	0.00447	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—KRAS—bile duct cancer	0.00437	0.00437	CbGpPWpGaD
Chloropyramine—PTK2—EPH-Ephrin signaling—HRAS—bile duct cancer	0.00437	0.00437	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—TGFB1—bile duct cancer	0.00423	0.00423	CbGpPWpGaD
Chloropyramine—PTK2—Integrin-mediated Cell Adhesion—HRAS—bile duct cancer	0.00416	0.00416	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—NRAS—bile duct cancer	0.00413	0.00413	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—MET—bile duct cancer	0.00399	0.00399	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—HRAS—bile duct cancer	0.00394	0.00394	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—IL6—bile duct cancer	0.00377	0.00377	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—EGFR—bile duct cancer	0.00376	0.00376	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—SMAD4—bile duct cancer	0.00372	0.00372	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—HRAS—bile duct cancer	0.00372	0.00372	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—GNAS—bile duct cancer	0.00372	0.00372	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—IL6—bile duct cancer	0.00356	0.00356	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—KRAS—bile duct cancer	0.00356	0.00356	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—HGF—bile duct cancer	0.00354	0.00354	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—EGFR—bile duct cancer	0.00352	0.00352	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—TP53—bile duct cancer	0.00348	0.00348	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—MMP2—bile duct cancer	0.00333	0.00333	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—KRAS—bile duct cancer	0.00333	0.00333	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—EGFR—bile duct cancer	0.0031	0.0031	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—TP53—bile duct cancer	0.00306	0.00306	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—ERBB2—bile duct cancer	0.00292	0.00292	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—RNF43—bile duct cancer	0.00286	0.00286	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—MET—bile duct cancer	0.00285	0.00285	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—HRAS—bile duct cancer	0.00283	0.00283	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.0028	0.0028	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—NOS2—bile duct cancer	0.00272	0.00272	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—MMP9—bile duct cancer	0.0025	0.0025	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—HRAS—bile duct cancer	0.00249	0.00249	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—MMP2—bile duct cancer	0.00238	0.00238	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—NRAS—bile duct cancer	0.00222	0.00222	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—GNAS—bile duct cancer	0.00208	0.00208	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—ERBB2—bile duct cancer	0.00208	0.00208	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—EGFR—bile duct cancer	0.00202	0.00202	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—KRAS—bile duct cancer	0.00191	0.00191	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—HGF—bile duct cancer	0.00186	0.00186	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—ERBB2—bile duct cancer	0.00184	0.00184	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—MMP9—bile duct cancer	0.00179	0.00179	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—HRAS—bile duct cancer	0.00162	0.00162	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—NRAS—bile duct cancer	0.00158	0.00158	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—IL6—bile duct cancer	0.00155	0.00155	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—NRAS—bile duct cancer	0.00155	0.00155	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—bile duct cancer	0.00154	0.00154	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—TGFB1—bile duct cancer	0.00147	0.00147	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—TGFB1—bile duct cancer	0.00144	0.00144	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—EGFR—bile duct cancer	0.00144	0.00144	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—RNF43—bile duct cancer	0.00143	0.00143	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bile duct cancer	0.00141	0.00141	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—NRAS—bile duct cancer	0.0014	0.0014	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—KRAS—bile duct cancer	0.00136	0.00136	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—KRAS—bile duct cancer	0.00134	0.00134	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—bile duct cancer	0.00133	0.00133	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TGFBR2—bile duct cancer	0.00131	0.00131	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—EGFR—bile duct cancer	0.00127	0.00127	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—GNAS—bile duct cancer	0.00126	0.00126	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—SMAD4—bile duct cancer	0.00124	0.00124	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—KRAS—bile duct cancer	0.0012	0.0012	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—TP53—bile duct cancer	0.00119	0.00119	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—GNAS—bile duct cancer	0.00118	0.00118	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—HRAS—bile duct cancer	0.00116	0.00116	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—HRAS—bile duct cancer	0.00114	0.00114	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	0.00113	0.00113	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—IL6—bile duct cancer	0.00111	0.00111	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	0.00108	0.00108	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—ERBB2—bile duct cancer	0.00107	0.00107	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—GNAS—bile duct cancer	0.00107	0.00107	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—HRAS—bile duct cancer	0.00102	0.00102	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—IL6—bile duct cancer	0.000979	0.000979	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—NRAS—bile duct cancer	0.000815	0.000815	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—EGFR—bile duct cancer	0.000742	0.000742	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—KRAS—bile duct cancer	0.000701	0.000701	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—ERBB2—bile duct cancer	0.000692	0.000692	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TGFBR2—bile duct cancer	0.000654	0.000654	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—GNAS—bile duct cancer	0.000631	0.000631	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—SMAD4—bile duct cancer	0.000619	0.000619	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—HRAS—bile duct cancer	0.000596	0.000596	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—MMP9—bile duct cancer	0.000594	0.000594	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IL6—bile duct cancer	0.00057	0.00057	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—NRAS—bile duct cancer	0.000527	0.000527	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TGFB1—bile duct cancer	0.000489	0.000489	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—EGFR—bile duct cancer	0.00048	0.00048	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—KRAS—bile duct cancer	0.000453	0.000453	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—NRAS—bile duct cancer	0.000446	0.000446	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—EGFR—bile duct cancer	0.000407	0.000407	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TP53—bile duct cancer	0.000403	0.000403	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—HRAS—bile duct cancer	0.000385	0.000385	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—KRAS—bile duct cancer	0.000384	0.000384	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—IL6—bile duct cancer	0.000369	0.000369	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—ERBB2—bile duct cancer	0.000347	0.000347	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—HRAS—bile duct cancer	0.000327	0.000327	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—IL6—bile duct cancer	0.000313	0.000313	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—MMP9—bile duct cancer	0.000297	0.000297	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—NRAS—bile duct cancer	0.000264	0.000264	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TGFB1—bile duct cancer	0.000245	0.000245	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—EGFR—bile duct cancer	0.00024	0.00024	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—KRAS—bile duct cancer	0.000227	0.000227	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TP53—bile duct cancer	0.000202	0.000202	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—HRAS—bile duct cancer	0.000193	0.000193	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—IL6—bile duct cancer	0.000185	0.000185	CbGpPWpGaD
